Case study of hepatitis C virus control in Egypt: impact of access program

Background Although Egypt was the country with the highest prevalence of hepatitis C in the world, the availability of sofosbuvir based therapies enabled Egypt to be the first country to eliminate hepatitis C and cure more than 4 million chronically infected patients. Purpose This is a small tribute...

Full description

Saved in:

Bibliographic Details
Published in:	Antiviral therapy 2022-04, Vol.27 (2), p.13596535211067592-13596535211067592
Main Author:	Waked, Imam
Format:	Article
Language:	eng
Subjects:	Egypt - epidemiology Hepacivirus Hepatitis C Hepatitis C - drug therapy Hepatitis C - epidemiology Hepatitis C - prevention & control Humans Prevalence Sofosbuvir - therapeutic use
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Background Although Egypt was the country with the highest prevalence of hepatitis C in the world, the availability of sofosbuvir based therapies enabled Egypt to be the first country to eliminate hepatitis C and cure more than 4 million chronically infected patients. Purpose This is a small tribute to John Martin. Methodology and conclusion Here I present a summary of the HCV problem in Egypt, and how we, through Gilead's Access program under his leadership, were able to eliminate the disease.
ISSN:	1359-6535 2040-2058